February 23, 202007 3346 3472stem.core@uq.edu.au

Staff Portfolio

Home / About Us / Staff Portfolio
  • Dmitry A. Ovchinnikov, PhD
    Dmitry A. Ovchinnikov, PhDScientific Director & General Manager

    Dmitry has a long record in molecular genetics, starting from some of the pioneering work on the mouse conditional genetics at the turn of the century, to more recent significant success with using the many forms of CRISPR/Cas9 technology to model normal development and disease in human pluripotent stem cells. In addition to that, Dmitry has a wealth of experience in generation and characterization of the induced pluripotent stem cell (iPSC) lines not only from humans cells, but also from many other mammals, including more exotic non-eutherian mammals. Using his expertise, the Core facility is expanding the range of offered services, and augment the comprehensive iPS generation and characterisation-related services with extensive range of CRISPR/Cas9-enabled and other advanced genome-manipulation technologies. Those will include genome editing (including the generation of large deletions  and seamless gene editing), as well as latest perivital genome visualization technologies.

  • Zhe Yang, PhD
    Zhe Yang, PhDLaboratory manager

    Dr Yang is an experienced researcher, with an extensive expertise in cell culture, including in experimentation on neuronal cells and their electrophysiology. She received her PhD from the  School of Biomedical Sciences (SBMS), and continued her training as a postdoctoral researcher at the Queensland Brain Institute at the University of Queensland. She also has a strong background in molecular cloning and a wealth of other modern biological techniques, supporting the expanding range of services and skills now being offered by the StemCore.


  • Ilaria Stefani, PhD
    Ilaria Stefani, PhDOperations/Administrative manager

    Ilaria was awarded a PhD in Bioengineering in 2014 with a project on vascular tissue regeneration developed at the Politecnico di Milano in collaboration with the Australian Institute for Bioengineering and Nanotechnology. She has 8 years of experience in tissue engineering and regenerative medicine research and 3 years of experience in research projects and grants management.

    Furthermore, she was a student of the Advance master course in Bioengineering system within the MIT/Portugal alliance. The course expanded her knowledge on patenting, commercialization paths, market analysis and research liaison with industry.